Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
A suite of engineered mice for interrogating psychedelic drug actions.Nature neuroscience · 2026-08-06Psilocybin for Fear of Cancer RecurrenceSupportive Care in Cancer · 2026-08-01Three cases of wood-lover paralysis: clinical insights from Victoria, Australia.Clinical toxicology (Philadelphia, Pa.) · 2026-07-01Specific and Multi-Product Clade I and Clade IV Sesquiterpene Synthases Contribute to the Psilocybe cubensis Volatilome.Chembiochem: a European journal of chemical biology · 2026-04-28Unlocking 'stuckness' and catalysing change: A qualitative study of clinician and service leader perspectives on psychedelic-assisted therapy for substance use and mental health problems.Addiction (Abingdon, England) · 2026-03-30Safety and Efficacy of Psilocybin-Assisted Therapy for Alcohol Use Disorder: Open-Label Extension of a Phase II Randomized Controlled TrialPsyArXiv · 2026-03-26A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populationsTherapeutic Advances in Psychopharmacology · 2026-02-28Mystical but Not Challenging Experiences Predict Symptom Improvement After Psilocybin for Treatment-Resistant OCDPsyArXiv · 2026-02-11Psilocybin for Treatment-Resistant OCD: A Randomized Controlled TrialPsyArXiv · 2026-01-15Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety.General hospital psychiatry · 2026-01-01Age and cannabis co-use are associated with differences in experience and perceived benefits of psilocybin: a retrospective studyPsyArXiv · 2025-12-10The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female MiceThe Journal of Neuroscience · 2025-12-10Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds.EClinicalMedicine · 2025-11-01Acute Kidney Failure and Myocarditis Triggered by Magic Mushroom Toxicity in a Patient With Prior Cocaine Exposure.Cureus · 2025-11-01Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial.Pilot and feasibility studies · 2025-10-28Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activationUNC Libraries · 2025-10-16Psychedelic use in individuals living with eating disorders or disordered eating: findings from the international MED-FED survey.Journal of eating disorders · 2025-07-24"I've learned that I'm open-minded to this possibility": A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke.Addiction science & clinical practice · 2025-07-21Clade III Synthases Add Cyclic and Linear Terpenoids to the Psilocybe Metabolome.Chembiochem: a European journal of chemical biology · 2025-07-11Beyond prohibition: A public health analysis of naturalistic psychedelic useJournal of Psychedelic Studies · 2025-07-03Age and cannabis co-use moderate experience and perceived benefits of psilocybinPsyArXiv · 2025-05-22ALSUntangled #77: Psilocybin.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025-05-01Psilocybin Dispensaries and Online Health Claims in Canada.JAMA network open · 2025-04-01Additional file 1 of “I’ve learned that I’m open-minded to this possibility”: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smokeFigshare · 2025-01-01Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial.The American journal of psychiatry · 2025-01-01A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life.PloS one · 2025-01-01Increased reactivity of the paraventricular nucleus of the hypothalamus and decreased threat responding in male rats following psilocin administrationUNC Libraries · 2024-10-22Insights into the efficacy of psilocybin in treating depression and other disordersBritish Journal of Neuroscience Nursing · 2024-08-01Prevalence of Psilocybin and Cannabis Concurrent Use During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health StudyDrug and Alcohol Dependence · 2024-07-01High Blood Pressure Among Psilocybin and Cannabis Consumers During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health StudyDrug and Alcohol Dependence · 2024-07-01Methodological issues undermine evidence about adverse effects of psilocybin-assisted psychotherapyPsyArXiv · 2024-05-17Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder.Cancer · 2024-04-01Psilocybe cubensis extract potently prevents fear memory recall and freezing behavior in short- but not long-term in a rat model of posttraumatic stress disorder.Behavioral neuroscience · 2024-04-01Rapid-acting antidepressant drugs modulate affective bias in rats.Science translational medicine · 2024-01-10The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov.Drug design, development and therapy · 2024-01-01The Potential Therapeutic Benefits and Safety of Psychedelics in the Treatment of Mental Health Conditions: A Systematic ReviewJournal of Sociology Psychology & Religious Studies · 2023-11-06A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issuesPsyArXiv · 2023-10-27Long term efficacy of psilocybin in patients with cancer and major depressive disorder (MDD).Journal of Clinical Oncology · 2023-05-31509. Meta-Analysis of Functional Neuroimaging Studies of the Effects of Serotonergic Psychedelics on Neural ActivityBiological Psychiatry · 2023-04-09The Effects of Serotonergic Psychedelics on Neural Activity: A Meta-Analysis of Task-Based Functional Neuroimaging StudiesEuropean Psychiatry · 2023-02-28Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients.Journal of affective disorders · 2023-02-15Exploring spp. mycelium and fruiting body chemistry for potential therapeutic compounds.Frontiers in fungal biology · 2023-01-01Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Frontiers in psychiatry · 2023-01-01Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.Contemporary clinical trials · 2022-12-01Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.JAMA psychiatry · 2022-10-01Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.BJPsych open · 2022-09-06Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations.Neuropharmacology · 2022-08-15The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder.Journal of Clinical Oncology · 2022-05-31Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain.Journal of fungi (Basel, Switzerland) · 2022-03-11Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment of alcohol dependence.Spirituality in Clinical Practice · 2021-09-01Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia-Relevance for Mental Diseases.Cells · 2021-07-27Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia NervosaOBM Neurobiology · 2021-06-24Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer.ACS pharmacology & translational science · 2021-04-09Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer.Journal of psychopharmacology (Oxford, England) · 2020-02-01Psilocybin for depression: Considerations for clinical trial designJournal of Psychedelic Studies · 2019-09-01Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.Frontiers in pharmacology · 2018-01-01Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy.Frontiers in pharmacology · 2018-01-01Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.Journal of psychopharmacology (Oxford, England) · 2016-12-01Evolution of the toxins muscarine and psilocybin in a family of mushroom-forming fungi.PloS one · 2013-01-01Patterns of recreational drug use at dance events in Edinburgh, Scotland.Addiction (Abingdon, England) · 2001-07-01